|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
KR20080088570A
(ko)
|
2005-08-10 |
2008-10-02 |
더 존스 홉킨스 유니버시티 |
항기생충 및 항암 치료제 및 라이신-특이적인 디메틸라제억제제로 유용한 폴리아민
|
|
EP2142287A4
(en)
|
2007-04-13 |
2012-05-23 |
Univ Johns Hopkins |
INHIBITORS OF LYSINPECIFIC DEMETHYLASE
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
WO2010143582A1
(ja)
|
2009-06-11 |
2010-12-16 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びlsd1阻害剤
|
|
US9708255B2
(en)
|
2009-08-18 |
2017-07-18 |
Robert A. Casero |
(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
MX2012012111A
(es)
|
2010-04-19 |
2013-05-30 |
Oryzon Genomics Sa |
Inhibidores de demetilasa-1 especifica de lisina y su uso.
|
|
AU2011244478B2
(en)
|
2010-04-20 |
2014-07-17 |
Fondazione IEO-CCM |
Tranylcypromine derivatives as inhibitors of histone demethylase LSD1 and/or LSD2
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
SI2598482T1
(sl)
*
|
2010-07-29 |
2018-09-28 |
Oryzon Genomics, S.A. |
Inhibitorji demetilaze lsd1 na osnovi arilciklopropilamina in njihova medicinska uporaba
|
|
US9527805B2
(en)
|
2010-09-10 |
2016-12-27 |
Robert A. Casero |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
WO2012071469A2
(en)
|
2010-11-23 |
2012-05-31 |
Nevada Cancer Institute |
Histone demethylase inhibitors and uses thereof for treatment o f cancer
|
|
CA2831143C
(en)
|
2011-03-25 |
2019-05-21 |
Glaxosmithkline Intellectual Property Development Limited |
Cyclopropylamines as lsd1 inhibitors
|
|
UA114406C2
(uk)
|
2011-08-09 |
2017-06-12 |
Такеда Фармасьютікал Компані Лімітед |
Похідні циклопропанаміну як інгібітори lsd1
|
|
SG2014009609A
(en)
*
|
2011-08-15 |
2014-05-29 |
Univ Utah Res Found |
Substituted (e)-n'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhiitors
|
|
WO2013033688A1
(en)
|
2011-09-01 |
2013-03-07 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer
|
|
CN107266345B
(zh)
|
2011-10-20 |
2021-08-17 |
奥瑞泽恩基因组学股份有限公司 |
作为lsd1抑制剂的(杂)芳基环丙胺化合物
|
|
RS58475B1
(sr)
|
2011-10-20 |
2019-04-30 |
Oryzon Genomics Sa |
Jedinjenja (hetero)aril ciklopropilamina kao lsd1 inhibitori
|
|
US9751885B2
(en)
|
2012-10-12 |
2017-09-05 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
EP2927212A4
(en)
|
2012-11-28 |
2016-06-08 |
Univ Kyoto |
LSD1-SELECTIVE HEMMER WITH LYSINE STRUCTURE
|
|
US9144555B2
(en)
|
2012-11-30 |
2015-09-29 |
Darlene E. McCord |
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
KR102288648B1
(ko)
|
2013-06-19 |
2021-08-12 |
유니버시티 오브 유타 리서치 파운데이션 |
히스톤 데메틸라제 억제제로서의 치환된 (e)-n′-(1-페닐에틸리덴)벤조하이드라지드 동족체
|
|
CN103319466B
(zh)
|
2013-07-04 |
2016-03-16 |
郑州大学 |
含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用
|
|
AU2014306149B2
(en)
|
2013-08-06 |
2019-09-19 |
Imago Biosciences Inc. |
KDM1A inhibitors for the treatment of disease
|
|
US9186391B2
(en)
|
2013-08-29 |
2015-11-17 |
Musc Foundation For Research Development |
Cyclic peptide inhibitors of lysine-specific demethylase 1
|
|
WO2015031564A2
(en)
|
2013-08-30 |
2015-03-05 |
University Of Utah |
Substituted-1h-benzo[d]imidazole series compounds as lysine-specfic demethylase 1 (lsd1) inhibitors
|
|
PL3080100T3
(pl)
|
2013-12-11 |
2023-03-06 |
Celgene Quanticel Research, Inc. |
Inhibitory lizyno-specyficznej demetylazy-1
|
|
US10118903B2
(en)
|
2014-02-07 |
2018-11-06 |
Musc Foundation For Research Development |
Aminotriazole-based KDM1A inhibitors as epigenetic modulators
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
NZ723203A
(en)
|
2014-02-13 |
2020-08-28 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
|
KR102421235B1
(ko)
|
2014-02-13 |
2022-07-15 |
인사이트 코포레이션 |
Lsd1 저해제로서 사이클로프로필아민
|
|
JP2017508798A
(ja)
|
2014-03-07 |
2017-03-30 |
ザ ジョンズ ホプキンス ユニバーシティ |
ヒストンリジン特異的デメチラーゼ（ｌｓｄ１）およびヒストンデアセチラーゼ（ｈｄａｃ）の阻害剤
|
|
CN103893163B
(zh)
|
2014-03-28 |
2016-02-03 |
中国药科大学 |
2-([1，1′-联苯]-4-基)2-氧代乙基4-((3-氯-4-甲基苯基)氨基)-4-氧代丁酸酯在制备lsd1抑制剂药物中的应用
|
|
SG11201608340UA
(en)
|
2014-04-11 |
2016-11-29 |
Takeda Pharmaceuticals Co |
Cyclopropanamine compound and use thereof
|
|
CN103961340B
(zh)
|
2014-04-30 |
2019-06-25 |
南通中国科学院海洋研究所海洋科学与技术研究发展中心 |
一类lsd1抑制剂及其应用
|
|
HUE057895T2
(hu)
|
2014-05-01 |
2022-06-28 |
Celgene Quanticel Res Inc |
Lizinspecifikus demetiláz-1 inhibitorai
|
|
AU2015265820C1
(en)
|
2014-05-30 |
2020-01-16 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
|
MX376632B
(es)
|
2014-06-27 |
2025-03-07 |
Celgene Quanticel Res Inc |
Inhibidores de demetilasa-1 especifica de lisina.
|
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
|
EA033698B1
(ru)
|
2014-07-03 |
2019-11-18 |
Celgene Quanticel Res Inc |
Ингибиторы лизинспецифической деметилазы-1
|
|
MX391865B
(es)
|
2014-07-03 |
2025-03-21 |
Celgene Quanticel Res Inc |
Inhibidores de demetilasa-1 especifica de lisina.
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
ES2935114T3
(es)
|
2014-09-05 |
2023-03-01 |
Celgene Quanticel Res Inc |
Inhibidores de la desmetilasa 1 específica de lisina
|
|
WO2016123387A1
(en)
|
2015-01-30 |
2016-08-04 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
KR102626978B1
(ko)
|
2015-02-12 |
2024-01-18 |
이마고 바이오사이언시즈 인코포레이티드 |
질환 치료를 위한 kdm1a 저해제
|
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
|
UA122688C2
(uk)
|
2015-04-03 |
2020-12-28 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як інгібітори lsd1
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
US10526287B2
(en)
|
2015-04-23 |
2020-01-07 |
Constellation Pharmaceuticals, Inc. |
LSD1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
US20170001970A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
JP7427363B2
(ja)
|
2015-08-12 |
2024-02-05 |
インサイト・ホールディングス・コーポレイション |
Ｌｓｄ１阻害剤の塩
|
|
RS61404B1
(sr)
|
2015-11-05 |
2021-02-26 |
Celgene Quanticel Research Inc |
Kompozicije koje sadrže inhibitor lizin specifične demetilaze-1 koje imaju pirimidinski prsten i njihova primena u lečenju kancera
|
|
US10059668B2
(en)
|
2015-11-05 |
2018-08-28 |
Mirati Therapeutics, Inc. |
LSD1 inhibitors
|
|
CA3006434C
(en)
|
2015-11-27 |
2021-03-16 |
Taiho Pharmaceutical Co., Ltd. |
Biphenyl compound or salt thereof
|
|
WO2017109061A1
(en)
|
2015-12-23 |
2017-06-29 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Spirocyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
SG11201805645QA
(en)
|
2015-12-29 |
2018-07-30 |
Mirati Therapeutics Inc |
Lsd1 inhibitors
|
|
BR112018013074A2
(en)
|
2015-12-30 |
2018-12-11 |
Novartis Ag |
immune effector cell therapies with enhanced efficacy
|
|
CN110267945A
(zh)
|
2016-03-01 |
2019-09-20 |
诺华股份有限公司 |
氰基取代的吲哚化合物及其作为lsd1抑制剂的用途
|
|
CN107200706A
(zh)
|
2016-03-16 |
2017-09-26 |
中国科学院上海药物研究所 |
一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途
|
|
US20170283397A1
(en)
|
2016-03-31 |
2017-10-05 |
University Of Utah Research Foundation |
Substituted 1-h-indol-3-yl-benzamide and 1, 1'-biphenyl analogs as histone demethylase inhibitors
|
|
SI3455204T1
(sl)
|
2016-05-09 |
2026-03-31 |
Jubilant Epicore LLC |
Ciklopropil-amidne spojine kot dvojni zaviralci lsd1/hdac
|
|
EP3246330A1
(en)
|
2016-05-18 |
2017-11-22 |
Istituto Europeo di Oncologia S.r.l. |
Imidazoles as histone demethylase inhibitors
|
|
CN107513068A
(zh)
|
2016-06-16 |
2017-12-26 |
中国科学院上海药物研究所 |
一种具有fgfr抑制活性的新型化合物及其制备和应用
|
|
CN106478639B
(zh)
|
2016-09-05 |
2018-09-18 |
郑州大学 |
嘧啶并1,2,4–三氮唑类的lsd1抑制剂、其制备方法及应用
|
|
CN106432248B
(zh)
|
2016-09-27 |
2018-11-27 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
|
WO2018081342A1
(en)
|
2016-10-26 |
2018-05-03 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
MD3532459T2
(ro)
|
2016-10-26 |
2024-06-30 |
Constellation Pharmaceuticals Inc |
Inhibitori ai LSD1 și utilizările medicale ale acestora
|
|
CN106831489B
(zh)
|
2017-03-23 |
2018-04-17 |
郑州大学 |
苯环丙胺酰腙类化合物、制备方法及其应用
|
|
CN106928235A
(zh)
|
2017-05-03 |
2017-07-07 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
|
SI3661510T1
(sl)
*
|
2017-08-03 |
2025-03-31 |
Oryzon Genomics, S.A. |
Postopki zdravljenja vedenjskih sprememb
|